Intensity Therapeutics, Inc. Announces First Patient Dosed in its Global Randomized, Phase III Study (INVINCIBLE-3) in Metastatic Soft Tissue Sarcoma

0
11
Intensity Therapeutics, Inc. announced that the first US patient has been dosed in the Company’s Phase IIIstudy to treat metastatic sarcoma.
[Intensity Therapeutics, Inc.]
Press Release